Outcomes not improved when PCI is facilitated with abciximab

摘要

Using abciximab plus reteplase or abciximab alone to facilitate percutaneous coronary intervention (PCI) does not improve clinical outcomes in patients with ST-segment elevation myocardial infarction,an international,multicentre study published this week shows.Furthermore,incidence of major haemorrhage was found to be increased (New England Journal of Medicine 2008;358:2205).